LineaGen Selects Affymetrix Technology to Discover Genes Associated With Autism and Multiple Sclerosis

Affymetrix Inc. (Nasdaq:AFFX) and LineaGen Inc. today announced that a team of prominent researchers at the University of Utah and Vanderbilt University are leveraging Utah’s deep domain expertise in human genetic research and the Affymetrix Genome-Wide Human SNP Array 6.0 to discover genetic markers associated with Multiple Sclerosis (MS) and Autism.

Source: Affymetrix, Inc.